Efficacy and safety of second-line ponatinib after failure of a single previous tyrosine kinase inhibitor for chronic myeloid leukemia patients in chronic phase

Massimo Breccia, Elisabetta Abruzzese, Alessandra Iurlo, Antonella Gozzini, Alessandro Isidori, Domenica Gangemi, Patrizia Pregno, Giuliana Alimena

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)e267-e268
Issue number6
Publication statusPublished - May 31 2016

ASJC Scopus subject areas

  • Hematology

Cite this